Opportunity for Public Comment - US Preventive Services Task Force

Opportunity for Public Comment - US Preventive Services Task Force

Draft Recommendation Statement and Draft Evidence Reviews: Screening for Illicit Drug Use

Public Comment on Draft Recommendation Statement and Draft Evidence Reviews: Screening for Illicit Drug Use, Including Nonmedical Use of Prescription Drugs The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and two draft evidence reviews on screening for illicit drug use, including nonmedical use of prescription drugs. The Task Force found that clinicians should screen all adults for illicit drug use. More research is needed to make a recommendation for teens. The draft recommendation statement and draft evidence reviews are available for review and public comment from August 13, 2019 to September 9, 2019 here. The Draft Recommendation Statement and Draft Evidence Reviews Are Open to Public Comment

COMMENTING DETAILS

Public Comment Period: 8/13/19 - 9/9/19 Any visitor to the Task Force Web site can comment on any of the listed USPSTF draft documents. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences.

DRAFT RECOMMENDATION SUMMARY

Population Recommendation Grade Adults age 18 years or older The USPSTF recommends screening for illicit drug use in adults age 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. B Adolescents The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for illicit drug use in adolescents. I

See the full draft recommendation statement

WHERE WE ARE IN THE PROCESS

Draft Research Plan Final Research Plan Draft Recommendation / Draft Evidence Review Final Recommendation / Evidence Summary